| Patient | Clara Barton |
|---|---|
| Date of birth | 1821-12-25 |
| Identifiers | MRN HR-NI024-SYN-TD; SSN (made up) 000-24-3357 |
| Document date | 2026-11-01 |
| Author | Eleanor Whitcombe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for low mood, exhaustion, and poor sleep after returning from a long humanitarian deployment. Concerns: Exhausted, low, and sleeping three or four hours a night since coming home; feels she is no use to anyone; Worried that stopping work would let down the families and staff who rely on her, and wonders whether she simply needs a long rest. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1874-01-20 to 1874-03-03 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1874-03-03 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth up to three times a day with food for no more than 7 days | One tablet up to three times a day with food, for no more than 7 days | Oral route | 1874-07-27 to 1874-08-02 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Advance care planning conversation, about 20 minutes | 1874-10-13 to 1874-10-13 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1873-10-06 | Influenza vaccine, 1873-1874 season | completed | S |
| 1872-05-13 | Tdap vaccine, before deployment | completed | S |
| 1874-10-13 | Influenza vaccine, 1874-1875 season | completed | S |
| 1874-10-13 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1874-10-13 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| Spring 1852 | Brief period of depression recorded in her diary while teaching | D (CLM-0002) |
| September 1862 | Typhoid fever after several days tending the wounded at Antietam | D (CLM-0003) |
| December 1868 | Loss of voice during a lecture from fatigue and mental prostration, then helpless through the winter; went to Europe on medical advice the next autumn | D (CLM-0006, CLM-0007) |
| 1872 to 1873 | Nervous exhaustion with temporary loss of eyesight; confined to bed for eight months with a cough in England | D (CLM-0009) |
| October 1873 | Breakdown with prostration of the nervous system after returning home | D (CLM-0010) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died in 1851; cause not recorded in the cited source | D (CLM-0016) | |
| father | Died in 1862; cause not recorded in the cited source | D (CLM-0016) |
| Concern | Status | Evidence |
|---|---|---|
| Exhausted, low, and sleeping three or four hours a night since coming home; feels she is no use to anyone | active | S |
| Worried that stopping work would let down the families and staff who rely on her, and wonders whether she simply needs a long rest | active | S |
Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1874-10-13; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 on 1874-10-13; PC-PTSD-5 score [PC-PTSD-5] 2 on 1874-01-20; Total score [AUDIT-C] 1 on 1874-10-13; Sodium [Moles/volume] in Serum or Plasma 139 on 1874-01-20; Potassium [Moles/volume] in Serum or Plasma 4.2 on 1874-01-20; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 1874-01-20; Urea nitrogen [Mass/volume] in Serum or Plasma 14 on 1874-01-20; Creatinine [Mass/volume] in Serum or Plasma 0.78 on 1874-01-20; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1869)/1.73 sq M 91 on 1874-01-20; Glucose [Mass/volume] in Serum or Plasma 92 on 1874-01-20; Hemoglobin [Mass/volume] in Blood 13.1 on 1874-01-20; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 1874-01-20; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 486 on 1874-01-20; Cholesterol [Mass/volume] in Serum or Plasma 196 on 1874-10-13; Cholesterol in HDL [Mass/volume] in Serum or Plasma 64 on 1874-10-13; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 1874-10-13; Triglyceride [Mass/volume] in Serum or Plasma 98 on 1874-10-13; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1874-10-13 [S]
Strengths and supports: Supports: a few close friends from earlier relief work, colleagues at the agency, and a faith community; no firearms in the home [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, recurrent, moderate (moderately severe symptoms at intake), after a prolonged humanitarian deployment; synthetic modern diagnosis linked to her documented periods of depression and nervous prostration | active | confirmed | F33.1 | S — Synthetic modern diagnosis. Her periods of depression and nervous prostration are documented in her own words (D); calling them major depression is a retrospective interpretation (R), and no diagnosis was made in her lifetime. |
| Occupational burnout after eighteen months leading field medical relief in a war zone | active | confirmed | Z73.0 | S — Synthetic contributing factor echoing her documented exhaustion after wartime relief work; burnout is an occupational phenomenon, not a mental disorder. |
| Acute low back strain after lifting supply crates, without red flags or radicular signs; resolved | resolved | confirmed | S39.012A | S — Synthetic strain at an unscheduled visit, chosen to teach NSAID and SSRI bleeding risk and activity advice during depression continuation treatment; it does not echo any documented injury. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1874-01-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 18 | {score} | S | ||
| 1874-01-20 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S | ||
| 1874-01-20 | PC-PTSD-5 score [PC-PTSD-5] | 2 | {score} | S | ||
| 1874-01-20 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 1874-01-20 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1874-01-20 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1874-01-20 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 1874-01-20 | Urea nitrogen [Mass/volume] in Serum or Plasma | 14 | mg/dL | 6-21 mg/dL | Normal | S |
| 1874-01-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1874-01-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1869)/1.73 sq M | 91 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1874-01-20 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1874-01-20 | Hemoglobin [Mass/volume] in Blood | 13.1 | g/dL | 12-15.5 g/dL | Normal | S |
| 1874-01-20 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1874-01-20 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 486 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1874-02-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | {score} | S | ||
| 1874-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 12 | {score} | S | ||
| 1874-04-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 1874-04-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | {score} | S | ||
| 1874-06-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1874-10-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1874-10-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | S | ||
| 1874-10-13 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 1874-10-13 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | <=199 mg/dL | Normal | S |
| 1874-10-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 64 | mg/dL | >=50 mg/dL | Normal | S |
| 1874-10-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 | mg/dL | <=129 mg/dL | Normal | S |
| 1874-10-13 | Triglyceride [Mass/volume] in Serum or Plasma | 98 | mg/dL | <=149 mg/dL | Normal | S |
| 1874-10-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1874-01-20 | Body height | 152 | cm | S |
| 1874-01-20 | Body weight | 49.8 | kg | S |
| 1874-01-20 | Body mass index (BMI) [Ratio] | 21.6 | kg/m2 | S |
| 1874-01-20 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1874-01-20 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1874-01-20 | Heart rate | 82 | /min | S |
| 1874-01-20 | Respiratory rate | 14 | /min | S |
| 1874-01-20 | Body temperature | 36.6 | Cel | S |
| 1874-01-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1874-02-03 | Body height | 152 | cm | S |
| 1874-02-03 | Body weight | 49.6 | kg | S |
| 1874-02-03 | Body mass index (BMI) [Ratio] | 21.5 | kg/m2 | S |
| 1874-02-03 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1874-02-03 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1874-02-03 | Heart rate | 78 | /min | S |
| 1874-02-03 | Respiratory rate | 14 | /min | S |
| 1874-02-03 | Body temperature | 36.5 | Cel | S |
| 1874-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1874-03-03 | Body height | 152 | cm | S |
| 1874-03-03 | Body weight | 50.2 | kg | S |
| 1874-03-03 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 1874-03-03 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1874-03-03 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1874-03-03 | Heart rate | 76 | /min | S |
| 1874-03-03 | Respiratory rate | 14 | /min | S |
| 1874-03-03 | Body temperature | 36.6 | Cel | S |
| 1874-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1874-04-14 | Body height | 152 | cm | S |
| 1874-04-14 | Body weight | 50.9 | kg | S |
| 1874-04-14 | Body mass index (BMI) [Ratio] | 22 | kg/m2 | S |
| 1874-04-14 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1874-04-14 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1874-04-14 | Heart rate | 72 | /min | S |
| 1874-04-14 | Respiratory rate | 14 | /min | S |
| 1874-04-14 | Body temperature | 36.6 | Cel | S |
| 1874-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1874-06-16 | Body height | 152 | cm | S |
| 1874-06-16 | Body weight | 51.6 | kg | S |
| 1874-06-16 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 1874-06-16 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1874-06-16 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1874-06-16 | Heart rate | 70 | /min | S |
| 1874-06-16 | Respiratory rate | 14 | /min | S |
| 1874-06-16 | Body temperature | 36.7 | Cel | S |
| 1874-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1874-07-27 | Body height | 152 | cm | S |
| 1874-07-27 | Body weight | 51.8 | kg | S |
| 1874-07-27 | Body mass index (BMI) [Ratio] | 22.4 | kg/m2 | S |
| 1874-07-27 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1874-07-27 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1874-07-27 | Heart rate | 84 | /min | S |
| 1874-07-27 | Respiratory rate | 16 | /min | S |
| 1874-07-27 | Body temperature | 36.7 | Cel | S |
| 1874-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1874-10-13 | Body height | 152 | cm | S |
| 1874-10-13 | Body weight | 52 | kg | S |
| 1874-10-13 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1874-10-13 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1874-10-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1874-10-13 | Heart rate | 68 | /min | S |
| 1874-10-13 | Respiratory rate | 14 | /min | S |
| 1874-10-13 | Body temperature | 36.6 | Cel | S |
| 1874-10-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1874-01-20 | Primary care visit for low mood, exhaustion, and poor sleep after returning from a long humanitarian deployment | finished | S |
| 1874-02-03 | Two-week sertraline tolerability and safety check, with psychiatry consultation | finished | S |
| 1874-03-03 | Six-week depression treatment review | finished | S |
| 1874-04-14 | Twelve-week depression treatment review | finished | S |
| 1874-06-16 | Five-month depression review in continuation treatment | finished | S |
| 1874-07-27 | Same-day sick visit for low back pain after lifting | finished | S |
| 1874-10-13 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Shared decision-making: combined psychotherapy and an antidepressant for a recurrent, moderately severe episode; she chose cognitive behavioral therapy and sertraline | completed | GL-MDD-2022, GL-CMID-2026 | S |
| Start sertraline 50 mg each morning; check tolerability and safety at two weeks; increase to 100 mg if the PHQ-9 has fallen by less than 50 percent after four to six weeks | completed | GL-MDD-2022, GL-CMID-2026 | S |
| Weekly cognitive behavioral therapy with the clinic psychologist, by video or in person, for about 16 sessions, including behavioral activation and insomnia components | completed | GL-MDD-2022, GL-CMID-2026 | S |
| Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; medicines stored safely and dispensed in 30-day supplies | completed | GL-SUICIDE-2024 | S |
| Psychiatry consultation to confirm the diagnosis, exclude bipolar disorder and PTSD, and advise on treatment of a recurrent episode | completed | GL-MDD-2022, GL-CMID-2026 | S |
| PHQ-9 at every visit and at least monthly until remission; suicide-risk review at every visit; continue sertraline for at least twelve months after remission because the episode is recurrent | completed | GL-MDD-2022, GL-CMID-2026, GL-SUICIDE-2024 | S |
| Burnout and work: two weeks of medical leave, then a phased return with a 45-hour cap, no field deployment for at least six months, delegation of the families' correspondence, and a peer support group for relief workers | completed | GL-MDD-2022, GL-CMID-2026 | S |
| Sleep and activity: fixed wake time, no work after 8 pm, a daily 30-minute walk, regular meals, and limited alcohol; prolonged bed rest or withdrawal from activity is explained as unhelpful for depression | completed | GL-MDD-2022, GL-CMID-2026 | S |
| Screen for bipolar disorder, PTSD, anxiety, and unhealthy alcohol use, and check thyroid, blood count, vitamin B12, and a metabolic panel for medical contributors to fatigue | completed | GL-MDD-2022, GL-CMID-2026, GL-USPSTF-DEP-2023 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Response (PHQ-9 down by at least 50 percent) by twelve weeks | 1874-04-14 | completed | PHQ-9 7 at twelve weeks, down 61 percent from 18 | S |
| Remission (PHQ-9 below 5) and continuation treatment for at least twelve months after remission | 1874-06-16 | active | Remission reached at five months (PHQ-9 4); continuation treatment under way | S |
| Sleep at least six hours most nights | 1874-04-14 | completed | About six and a half hours most nights by twelve weeks | S |
| Phased return to work at no more than 45 hours a week, with no field deployment for at least six months | 1874-06-16 | completed | Full duties at 45 hours a week from April; no deployment | S |
| Time with friends or her faith community at least twice a week | 1874-06-16 | completed | Weekly dinner with friends and weekly services | S |
Structured synthetic safety assessment on 1874-01-20: current ideation absent, intent absent, plan absent. Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, safe storage of medicines, and a two-week follow-up [S]